| Antimicrobial Agent | Susceptibility Profile | Clinical Interpretation |
|---|---|---|
| Amikacin | Sensitive | 4 |
| Amoxicillin/Clavulanic acid | Resistant | >=32 |
| Cefepime | Sensitive | 1 |
| Ceftriaxone | Resistant | 8 |
| Cefuroxime | Intermediate | 16 |
| Ciprofloxacin | Resistant | >=4 |
| Colistin | Resistant | >=16 |
| Ertapenem | Sensitive | <=0.12 |
| Fosfomycin | Sensitive | <=16 |
| Gentamicin | Intermediate | 4 |
| Imipenem | Sensitive | <=0.25 |
| Meropenem | Sensitive | <=0.25 |
| Piperacillin/Tazobactam | Sensitive | <=4 |
| Trimethoprim/Sulfamethoxazole | Sensitive | <=20 |
| Resistant Gene Track | Detection Methodology | NCBI Genome Accession |
|---|---|---|